CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
One-Lung ventilation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00534690
NCT00534690N/ACompleted

Lowering VT and Increasing PEP During One-Lung Ventilation (OLV), Impact on Oxygenation

University Hospital, Bordeaux·interventional·Posted Sep 26, 2007·Updated May 15, 2026

In Brief

A clinical study evaluating One-Lung ventilation and One-Llung ventilation for Lung Neoplasms and Pulmonary Disease. Completed, enrolled 88 participants across 1 site.

Detailed Summary

During general anesthesia, airway closure and the formation of atelectasis impair oxygenation. During one-lung ventilation, large tidal volumes are used to resume atelectasis with a risk of regional over distension and Ventilator-Induced Lung Injury (VILI). The reduction in TV should reduce the occurrence of VILI but lead to a consistent alveolar derecruitment. This harmful effect may be counteracted by PEP. We, therefore, study the impact on oxygenation, of increasing PEP during OLV, in order to maintain alveolar recruitment when TV is reduced.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2007
Enrollment StartNov 1, 2007
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 18.8 years ago

Interventions

One-Lung ventilationprocedure

Low Vt, High PEP

One-Llung ventilationprocedure

High Vt, low PEP